|
PRODUCTS |
THERAPEUTIC CATEGORY |
CAS NUMBER |
REGULATORY/DMF STATUS |
|
Albendazole |
Anthelmintic |
54965-21-8 |
DMF |
|
Amantadine Hydrochloride |
Anti Viral |
665-66-7 |
DMF to be filed |
|
Apixaban |
Anti Coagulant |
503612-47-3 |
DMF |
|
Ascorbic Acid |
Vitamin C |
50-81-7 |
DMF |
|
Baricitinib* |
Anti Arthritis |
1187594-09-7 |
DMF to be filed |
|
Brexpiprazole |
Atypical Antipsychotic Agent |
913611-97-9 |
DMF |
|
Brivaracetam* |
Anti Convulsant |
357336-20-0 |
DMF |
|
Calcium Dobesilate Monohydrate |
Vasoprotective |
117552-78-0 |
CEP 2023-106-Rev 00, KFDA, DMF |
|
Carbamazepine |
Anti Convulsant |
298-46-4 |
CEP 2021-339-Rev 01, DMF |
|
Cenobamate* |
Anti Convulsant |
913088-80-9 |
DMF |
|
Chlorhexidine Base |
Disinfectant |
55-56-1 |
DMF |
|
Chlorhexidine Diacetate |
Disinfectant |
56-95-1 |
DMF to be filed |
|
Chlorhexidine Digluconate 20% Solution |
Disinfectant |
18472-51-0 |
R0-CEP 2017-074-REV 02, TFDA, DMF |
|
Chlorhexidine Dihydrochloride |
Disinfectant |
3697-42-5 |
DMF |
|
Choline Theophyllinate |
Anti Asthamatic |
4499-40-5 |
DMF to be filed |
|
Citicoline Sodium |
Neuro Protective |
33818-15-4 |
DMF |
|
Cyclizine HCL |
Anti Histamine |
303-25-3 |
CEP 2024-447-Rev 00 |
|
Deferasirox |
Iron Chelator |
201530-41-8 |
DMF |
|
Diosmin Hesperidin |
Vasoprotective |
520-27-4 |
DMF |
|
Doxofylline |
Anti Asthamatic |
69975-86-6 |
DMF. KFDA |
|
Famciclovir |
Anti Viral |
104227-87-4 |
DMF. TGA-e007785 |
|
Ferric Carboxymaltose |
Iron Replacement Agent |
9007-72-1 |
DMF. KFDA |
|
Ferrous Ascorbate |
Anti Anemic |
24808-52-4 |
DMF |
|
Fosfomycin Calcium |
Urinary Tract Infection |
26016-98-8 |
DMF |
|
Fosfomycin Sodium |
Urinary Tract Infection |
26016-99-9 |
DMF |
|
Fosfomycin Trometamol |
Urinary Tract Infection |
78964-85-9 |
DMF, KFDA |
|
Lacosamide |
Anti Convulsant |
175481-36-4 |
DMF to be filed |
|
Lafutidine |
Antagonist |
118288-08-7 |
KFDA |
|
Lasmitidan |
Anti Migraine |
439239-90-4 |
DMF, KFDA |
|
Leflunomide |
Anti Rheumatic |
75706-12-6 |
DMF, KFDA |
|
Linagliptin* |
Anti Diabetic |
668270-12-0 |
DMF |
|
Metronidazole Benzoate |
Antibiotic |
13182-89-3 |
CEP 2023-417-Rev 00, DMF |
|
Nimesulide |
NSAID |
51803-78-2 |
DMF, CEP Filed |
|
Noscapine |
Anti Tussive |
128-62-1 |
DMF to be filed |
|
Octenidine Dihydrochloride |
Disinfectant |
70775-75-6 |
DMF. KFDA. ASMF |
|
Octopamine Hydrochloride |
Weight Reducing |
770-05-8 |
DMF to be filed |
|
Oxcarbazepine |
Anti Convulsant |
28721-07-5 |
CEP 2021-340-Rev 01, DMF |
|
Pentoxyfylline |
Hemorheologic agent |
6493-05-6 |
DMF |
|
Papaverine HCL |
Vasodilator |
61-25-6 |
DMF to be filed |
|
Pimavanserin |
Anti Psychotic |
706779-91-1 |
DMF |
|
Polyhexamethylene Biguanide(PHMB) |
Disinfectant |
32289-58-0 |
DMF to be filed |
|
Ractopamine |
Beta Agonist |
97825-25-7 |
DMF to be filed |
|
Recoflavone |
Gastroretentive Drug |
203191-10-0 |
DMF to be filed |
|
Rivaroxaban |
Anti Coagulant |
366789-02-8 |
CEP 2023-085-Rev 00, DMF |
|
Roxadustat |
Anti Anemic |
808118-40-3 |
DMF to be filed |
|
Sacubitril Sodium |
Hypertension |
149690-05-01 |
DMF |
|
Sacubitril Valsartan |
Hypertension |
936623-90-4 |
DMF, KFDA |
|
Sitagliptin HCL |
Anti Diabetic |
486459-71-6 |
DMF |
|
Sitagliptin Phosphate Monohydrate |
Anti Diabetic |
654671-77-9 |
DMF, KFDA |
|
Sodium Ascorbate |
Vitamin C |
134-03-2 |
DMF |
|
Suvorexant |
Antagonist |
1030377-33-3 |
DMF |
|
Trazodone HCL |
Antagonist |
25332-39-2 |
CEP 2023-228 Rev 00, DMF |
|
Upadacitinib Hemihydrate* |
Anti Arthritis |
2050057-56-0 |
DMF to be filed |
|
Vildagliptin |
Anti Diabetic |
274901-16-5 |
TFDA, DMF, KFDA |
|
|
|
|
|
|
All API's are available with Nitrosamines/NDMAs risk assessment and evaluation reports. |
|
|
|
|
|
|
|
|
|
*Products protected by valid patents are not offered for sale in Countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk* |
|
|
|
|
|
|
|
|
